Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Pancreatic Cancer”

636 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 636 results

Testing effectiveness (Phase 2)WithdrawnNCT00882765
What this trial is testing

Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT02308722
What this trial is testing

SBRT Pre-operatively for Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
University of Oxford 12
Early research (Phase 1)Study completedNCT00739453
What this trial is testing

Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Testing effectiveness (Phase 2)Study completedNCT00810953
What this trial is testing

A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy

Who this might be right for
Pancreatic Cancer
Oncozyme Pharma Inc. 10
Early research (Phase 1)Study completedNCT00056537
What this trial is testing

ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaRenal Cell CarcinomaPancreatic Cancer
Active Biotech AB 44
Early research (Phase 1)Study completedNCT00626158
What this trial is testing

Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers

Who this might be right for
Pancreatic CancerBiliary Cancer
University of California, San Francisco 45
Testing effectiveness (Phase 2)WithdrawnNCT00253526
What this trial is testing

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage I Pancreatic Cancer+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT00900016
What this trial is testing

Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery

Who this might be right for
Pancreatic Cancer
Fox Chase Cancer Center 37
Testing effectiveness (Phase 2)Ended earlyNCT03009058
What this trial is testing

Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer

Who this might be right for
Metastatic Cancer
Immodulon Therapeutics Ltd 2
Early research (Phase 1)Study completedNCT05383352
What this trial is testing

Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Ipsen 177
Early research (Phase 1)Study completedNCT01897415
What this trial is testing

Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer

Who this might be right for
Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
University of Pennsylvania 16
Early research (Phase 1)Study completedNCT02227940
What this trial is testing

Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmALK PositiveMetastatic Pancreatic Adenocarcinoma+2 more
Roswell Park Cancer Institute 38
Early research (Phase 1)Looking for participantsNCT05687123
What this trial is testing

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Who this might be right for
Metastatic Pancreatic Neuroendocrine TumorPancreatic NeoplasmStage III Pancreatic Neuroendocrine Tumor AJCC v8+2 more
National Cancer Institute (NCI) 24
Early research (Phase 1)UnknownNCT01218880
What this trial is testing

Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Protgen Ltd 21
Not applicableLooking for participantsNCT06595160
What this trial is testing

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8
Emory University 87
Testing effectiveness (Phase 2)Study completedNCT00411762
What this trial is testing

A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
Yale University 25
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Early research (Phase 1)UnknownNCT04801095
What this trial is testing

A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorColorectal Cancer+4 more
Wellmarker Bio 100
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Load More Results